Page 390 - v11i4
P. 390

International Journal of Bioprinting                                      Bioprinted vascular tumor model




            anti-rabbit IgG at 4 μg/mL. Staining results were imaged   conforming to a normal distribution were subjected to
            using the CQ1 fluorescence microscope to analyze protein   parametric analysis. The p-values were calculated via a two-
            expression and localization.                       tailed Student’s t-test for comparisons between two groups
                                                               or one-way analysis of variance (ANOVA) for multiple
            2.12. Cytoskeleton staining                        group comparisons. Significance levels are indicated as *
            Fixed and permeabilized samples were stained with   for p < 0.05, ** for p < 0.01, *** for p < 0.001, and N.S. for
            Phalloidin-FITC (10 μg/mL) in the dark at room     no significant difference.
            temperature for 1 h. After three washes with PBST (0.1%
            Triton X-100 in PBS, pH 7.4), samples were imaged using   3. Results and discussion
            the CQ1 system under 488 nm excitation to visualize
            cytoskeletal structures.                           3.1. Fabrication of hollow tubes using
                                                               a coaxial nozzle
            2.13. Quantitative reverse transcription polymerase   To achieve a balance between the mechanical properties
            chain reaction                                     and biocompatibility of the hollow tubes, we systematically
            Gene expression was analyzed by quantitative reverse   investigated the  formulation  of alginate, collagen, and
            transcription polymerase chain reaction (qRT-PCR). Total   GelMA in the bioink. As displayed in Figure 2A, under a
            RNA was extracted using a commercial kit following the   fixed GelMA concentration of 3% (w/v), stable hollow tube
            manufacturer’s instructions. RNA concentration and purity   formation was achieved when the alginate concentration
            were assessed using a microvolume spectrophotometer (LB   ranged from 1% to 1.5% (w/v) and collagen was maintained
            915; Colibri, Germany). Complementary DNA (cDNA)   at 5 mg/mL. However, this formulation exhibited limited
            was synthesized from RNA using a commercial reverse   biocompatibility and failed to support the formation of a
            transcription kit. SYBR Green-based qRT-PCR (Roche,   dense endothelial layer. Through further optimization, we
            Switzerland) was  performed  using primers  listed  in    found that increasing the collagen concentration to 8 mg/
            Table 1. Gene expression was normalized to glyceraldehyde-  mL while maintaining alginate at 1% (w/v) resulted in a
            3-phosphate dehydrogenase (GAPDH) and analyzed using   composite bioink (3% GelMA, 1% alginate, and 8 mg/mL
            the 2 −ΔΔCt  method.                               collagen) with the best overall performance in terms of
                                                               printability, structural integrity, and cellular compatibility.
            2.14. Statistical analysis                         Unlike coaxial strategies relying on homogeneous
            Quantitative data are presented as mean ± standard   bioinks, 38,39  our  approach  achieves  dual-layered
            deviation (SD) for at least three samples per test (n ≥ 3).    microvessels with physiological mechanical properties
            Prior to statistical testing, all datasets were assessed   and sustained cell viability. To meet the requirements for
            for normality using the Shapiro-Wilk test. Only data   constructing multiscale vascular networks, we further



            Table 1. Primer sequences

                                                           Primer sequence (5’–3’)
             Gene
                                            Forward                                   Reverse
             GAPDH                 ACAACTTTGGTATCGTGGAAGG                      GCCATCACGCCACAGTTTC
             CD40                   GCTTCTTCTCCAATCAGTCAT                     ACCTCCAAGTTCTTATCCTCA
             Casp-4                  CTACGATGTGGTGGTGAA                        TGATGTCTGGTGTTCTGAG
             CD44                   AGAAGGTGTGGGCAGAAGAA                      AAATGCACCATTTCCTGAGA
             CD70                    TGCTGCTGGTGGTGTTTA                        CCTCTGTTGCTGCTTACTGA
             CD133                  GGCCCAGTACAACACTACCAA                     ATTCCGCCTCCTAGCACTGAA
             CXCL12                  TGCCAGAGCCAACGTCAAG                      CAGCCGGGCTACAATCTGAA
             CXCR4                  TGACGGACAAGTACAGGCTGC                     CCAGAAGGGAAGCGTGATGA
             Fas                     GTTGTTGACCATCCTTGTT                       TCACGACTGGAGGTTCTA
             MMP2                GTGCTGAAGGACACACTAAAGAAGA                  TTGCCATCCTTCTCAAAGTTGTAGG
             MMP9                   AGACCTGGGCAGATTCCAAAC                     CGGCAAGTCTTCCGAGTAGT
             N-cadherin             AGCCAACCTTAACTGAGGAGT                     GGCAAGTTGATTGGAGGGATG
             Tnfrsf11b               AGAGTGAGGCAGGCTATT                        TGAGGAGAGGAAGGAAGG


            Volume 11 Issue 4 (2025)                       382                            doi: 10.36922/IJB025180180
   385   386   387   388   389   390   391   392   393   394   395